BioSpace News Archive

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced financial results for the first quarter ended March 31, 2022.

Bioventus Inc., a global leader in innovations for active healing, reported financial results for three months ended April 2, 2022.

Akari Therapeutics, plc (Nasdaq: AKTX), a late-stage biotechnology company focused on development of advanced therapies for autoimmune and inflammatory diseases, announced positive results from the Phase II study of investigational nomacopan in bullous pemphigoid (BP) were published online in the Journal of the American Medical Association (JAMA) Dermatology.

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today outlined seven presentations from across its platform to be featured at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting taking place May 16-19 in Washington, D.C.

Taysha Gene Therapies, Inc. announced oral and poster presentations and a company-sponsored symposium at the upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy taking place in Washington, D.C. from May 16-19, 2022.

SOPHiA GENETICS SA, a leader in data-driven medicine, reported financial results for the first quarter ended March 31, 2022.

DENTSPLY SIRONA Inc. announced its preliminary financial results for the first quarter of 2022.

iSpecimen Inc. reported its financial and operating results for the three-month period ended March 31, 2022.

Bausch Health Companies Inc. announced its first-quarter 2022 financial results.

Bio-Techne Corporation announced that Exosome Diagnostics, a Bio-Techne brand, will have a major scientific presence at the annual American Urological Association Conference taking place May 13-16 in New Orleans, LA.